We tried to identify clinical, laboratory and imaging parameters that may predict ... and a significant cost burden on patients with liver cirrhosis. As the prevalence of LEVx is only 9-36% ...

Primary Biliary Cholangitis Clinical Trial Pipeline Pharmaceutical companies are advancing the Primary Biliary Cholangitis treatment pipeli ...

Nonalcoholic steatohepatitis (NASH) is the progressive form of liver injury that carries a risk for progressive fibrosis, cirrhosis ... cannot be detected by imaging studies or laboratory tests.

Innovative therapies and surgical techniques have the potential to transform liver cancer care. People with cirrhosis—a ...

Recent research suggests that a new approach could help even patients with advanced forms of fatty liver disease.

Researchers describe successful tumor removal through the use of immunotherapy and targeted radiation therapy (TARE), in a patient previously considered ineligible for the procedure.

The risk of developing liver cancer is increased in people who have cirrhosis, a disease in which healthy liver tissue is ...

Discover a potential breakthrough in treating severe liver scarring with a safe and effective therapy, as revealed by a recent Cleveland Clinic-led study.

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

These health conditions contribute to a buildup of fat in the liver, experts say, which can then lead to fibrosis or scarring of the liver.

Human uptake of microplastic particles (MPs) is causing increasing health concerns, and there is mounting pressure to evaluate the associated risks. While MPs can be ingested, breathed in, or drank in ...